Endoscopic sclerotherapy of gastric XXXX with @entity7548 .

@entity1 @entity82 @entity101 @entity548 @entity7548 @entity4831 @entity432 @entity2312 @entity360
BACKGROUND: @entity548 from @entity2312 is a life-threatening complication of portal @entity101 . Fundal and isolated @entity2312 are at high risk for @entity548 . In this study, we report our experience with @entity7548 (BC) in @entity1 with large @entity2312 . STUDY: twenty-nine @entity1 (15 male, 14 female) with large fundal varices (active bleed, 5; passive bleed after eradication of esophageal varices, 13; unbled fundal varices with red color sign, 11) underwent endoscopic sclerotherapy with BC. @entity82 was present in 13 @entity1 ; extrahepatic portal @entity432 , in 13; and noncirrhotic portal @entity82 , in 3. @entity7548 after mixing with @entity4831 (1:1) was given to the initial 10 @entity1 and was given in undiluted form to the remaining @entity1 , followed by injection of 0.7 mL of distilled water to rinse the injection catheter. One to three injections (0.5-1 mL) were given until all @entity2312 became hard. All @entity1 were on long-term endoscopic sclerotherapy or variceal ligation programs for eradication of esophageal varices. RESULTS: acute @entity548 was controlled in all five @entity1 with BC injections. Eradication of @entity2312 was achieved in 27 (93.1%) @entity1 (20 @entity1 in 1 session, 4 @entity1 in 2, and 3 @entity1 in 3-6). Rebleeding occurred in three (10.3%) @entity1 who responded to repeat BC injections. Complications related to the procedure occurred in two (6.9%) @entity1 . In one @entity1 , the needle became impacted into the tissue adhesive. This @entity1 died 5 days later because of massive @entity360 . In the other @entity1 , there was distal embolization. CONCLUSIONS: sclerotherapy of @entity2312 with BC is a safe and an effective treatment for control of @entity548 and eradication. The needle should be withdrawn immediately after the BC injection to prevent its impaction into the tissue adhesive.
